Calvert Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-103,648
Closed -$6.49M 5
2016
Q4
$6.49M Sell
103,648
-542
-0.5% -$33.1K 0.24% 115
2016
Q3
$6.57M Buy
104,190
+6,233
+6% +$404K 0.24% 121
2016
Q2
$6.07M Buy
97,957
+5,481
+6% +$334K 0.24% 123
2016
Q1
$5.28M Buy
92,476
+6,882
+8% +$384K 0.23% 95
2015
Q4
$5.07M Buy
85,594
+14,836
+21% +$855K 0.23% 84
2015
Q3
$3.85M Sell
70,758
-217
-0.3% -$14.1K 0.19% 117
2015
Q2
$4.77M Sell
70,975
-166
-0.2% -$10.8K 0.21% 110
2015
Q1
$4.17M Buy
71,141
+7,261
+11% +$439K 0.27% 106
2014
Q4
$4.18M Buy
63,880
+5,713
+10% +$360K 0.29% 100
2014
Q3
$3.36M Buy
58,167
+43,073
+285% +$2.39M 0.25% 113
2014
Q2
$852K Sell
15,094
-296
-2% -$15.5K 0.06% 182
2014
Q1
$791K Sell
15,390
-99
-0.6% -$5K 0.06% 185
2013
Q4
$818K Buy
15,489
+221
+1% +$10.9K 0.06% 187
2013
Q3
$683K Buy
+15,268
New +$677K 0.09% 184

Other funds holding ABBV

Calvert Investment Management's ABBV Position: Q1 2017 in Review

Calvert Investment Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 103,648 shares — an estimated $6.49M sold.

Calvert Investment Management first reported a position in ABBV in Q3 2013 and held it in 14 quarters. The position peaked at $6.57M in Q3 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Calvert Investment Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 103,648 AbbVie shares in Q1 2017, an estimated $6.49M.
  • Calvert Investment Management first reported a position in AbbVie in Q3 2013 and held it in 14 quarters.
  • Calvert Investment Management's AbbVie position peaked at $6.57M in Q3 2016.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.